OTC Markets OTCPK · Biotechnology

Ampio Pharmaceuticals Inc (AMPE)

Stock, pipeline and biotech catalyst intelligence

Analyst view

Not covered

Ratings unavailable

$0.18+0.00 (+0.0%)Latest market snapshot · Yahoo Finance

Market cap$207,884

Cash$4.1M

Quarterly burn—

Pipeline assets2

Short float2.9%

Market expectations

Analyst Ratings & Price Targets

Data may be delayed

Street view at a glance

Analyst expectations are available belowTargets are estimates—not guarantees—and can change after company updates.

—Average target

Wall Street consensus

Not availableCoverage varies by company

—ratings

Buy 0Hold 0Sell 0

Price-target range

—

Low —High —

CurrentAverage

Bear case——

Base case——

Bull case——

Analyst coverage—published opinions

Bullish share—buy recommendations

Target spread—low-to-high dispersion

Consensus score—1.0 is strongest

Recommendation mix

Current rating breakdown

0 tracked ratings

No detailed rating distribution is available.

Company profile

About Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.

Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.